Dr. Adam Charles Yopp, MD

Dr. Yopp practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Yopp's NPI, 1992965735, was assigned on June 16, 2008. Dr. Yopp graduated from St. George's University School of Medicine in 2000. Dr. Yopp holds Texas license N4215.

Dr. Yopp's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Yopp's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Yopp is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Yopp to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yopp practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Yopp's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Yopp is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Yopp's licenses on file in 2 states: Texas and New York.

Dmand AI lists intestinal or bowel obstruction among the conditions Dr. Yopp treats.

CMS data shows 175 Medicare services from Dr. Yopp across 3 procedure codes in 2024, for 146 Medicare patients. Medicare paid $14,979 for them.

CMS counts 146 Medicare patients who saw Dr. Yopp in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yopp's median patient age at 65, with 52% women.

In 2024, Dr. Yopp wrote 113 Medicare Part D claims for 45 patients. 84% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $495 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Yopp for performance year 2024, reported as part of a group. Dr. Yopp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yopp as offering telehealth.

Dmand AI links 260 papers to Dr. Yopp, published from 2011 to 2025. 2020 was the busiest year, with 33. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Liver Cirrhosis. Dr. Yopp has published most often in Ann Surg Oncol. Dr. Yopp's most frequent co-authors are Amit Singal, MD, John C. Mansour, MD and Matthew Ryan Porembka, MD.

Dmand AI links Dr. Yopp to 2 clinical trials. Conditions studied include Carcinoma, Hepatocellular, Fibrosis and Liver Neoplasms. University of Texas Southwestern Medical Center sponsors the most, 2.

CMS Open Payments shows 26 general payments to Dr. Yopp from 6 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Genentech, Inc. paid the most, $25,957.

Dmand AI lists 2 awards for Dr. Yopp, most recently CMS Stage 1 EHR in 2011.

Dr. Yopp graduated from St. George's University School of Medicine in 2000. Dr. Yopp is a member of ACS.

Dr. Yopp is in network with 23 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.